Next Article in Journal
Phenolics as Chemosystematic Markers in and for the Genus Crepis (Asteraceae, Cichorieae)
Previous Article in Journal
Effect of Cerebral Ischemia/Reperfusion Injury on Hydroxysafflor Yellow A Penetrating Across the Blood-Brain Barrier
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Comparative Study of Femineral® and Floradix® in Women of Child-Bearing Age and Adolescent Girls with Iron Deficiency Anaemia

by
Sofia BABAYAN
1,
Gayane ASLANYAN
2,
Elmira AMROYAN
3,
Emil GABRIELYAN
3,
Georg WIKMAN
4 and
Alexander G. PANOSSIAN
4,*
1
Polyclinic No 8, Ministry of Health of Armenia, Yerevan, Armenia
2
Department of Clinical Pharmacology, Armenian National Institute of Health, Yerevan, Armenia
3
Scientific Centre of Drug and Medical Technology Expertise, Ministry of Health of Armenia, 375001, Yerevan, Armenia
4
SHI Research and Development, Spårvägen 2, SE-432 96 Åskloster, Sweden
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2008, 76(4), 725-742; https://doi.org/10.3797/scipharm.0807-17
Submission received: 24 July 2008 / Accepted: 30 October 2008 / Published: 1 November 2008

Abstract

This double blind randomised trial compared the clinical efficacy of Femineral®, a proprietary herbal preparation containing highly soluble iron compounds, minerals, and vitamins, with Floradix®, the most popular iron supplement in Scandinavia for patients with iron deficiency anaemia (IDA).
Fifty women of childbearing age and adolescent girls, all diagnosed with IDA, were randomised into two groups. One group (n = 26) was treated with Femineral (10 ml twice a day; 15 mg of iron supplement/day), while the second (n = 24) received Floradix® (10 ml twice a day; 20 mg of iron supplement/day). The efficacy of 28 days of treatment in each group was evaluated by analysis of serum iron levels, blood haemoglobin and erythrocyte counts; by the mental performance of the patients on days one and 28; and by assessment of IDA symptoms, such as pale skin colour, fatigue, irritability, weakness, constipation, brittle nails, cold hands and feet, headache, blue tinge to sclera, and feeling of well being on days one, seven, 14 and 28.
The Femineral group showed significant improvements in blood haemoglobin levels and red cell counts after 28 days, while the Floradix group did not. The Femineral group showed better improvements in other IDA symptoms, such as impaired mental performance, pale skin colour, fatigue, irritability, weakness, constipation, brittle nails, cold hands and feet. Both groups showed significant improvements in serum iron levels at the end of the study. Such improvements correlate with the results of memory tests: the number of errors by both groups was significantly lower at the end of the study. There were no significant differences in memory tests between the two groups. Eight patients in the Floradix group and one in the Femineral group reported drowsiness. The Femineral group reported two other adverse events (nausea and vomiting). Femineral can be used safely in the treatment of iron deficiency anaemia. It is more efficient and safe than Floradix.
Keywords: Herbal preparations; Iron deficiency and anaemia; Clinical trial Herbal preparations; Iron deficiency and anaemia; Clinical trial

Share and Cite

MDPI and ACS Style

BABAYAN, S.; ASLANYAN, G.; AMROYAN, E.; GABRIELYAN, E.; WIKMAN, G.; PANOSSIAN, A.G. Comparative Study of Femineral® and Floradix® in Women of Child-Bearing Age and Adolescent Girls with Iron Deficiency Anaemia. Sci. Pharm. 2008, 76, 725-742. https://doi.org/10.3797/scipharm.0807-17

AMA Style

BABAYAN S, ASLANYAN G, AMROYAN E, GABRIELYAN E, WIKMAN G, PANOSSIAN AG. Comparative Study of Femineral® and Floradix® in Women of Child-Bearing Age and Adolescent Girls with Iron Deficiency Anaemia. Scientia Pharmaceutica. 2008; 76(4):725-742. https://doi.org/10.3797/scipharm.0807-17

Chicago/Turabian Style

BABAYAN, Sofia, Gayane ASLANYAN, Elmira AMROYAN, Emil GABRIELYAN, Georg WIKMAN, and Alexander G. PANOSSIAN. 2008. "Comparative Study of Femineral® and Floradix® in Women of Child-Bearing Age and Adolescent Girls with Iron Deficiency Anaemia" Scientia Pharmaceutica 76, no. 4: 725-742. https://doi.org/10.3797/scipharm.0807-17

APA Style

BABAYAN, S., ASLANYAN, G., AMROYAN, E., GABRIELYAN, E., WIKMAN, G., & PANOSSIAN, A. G. (2008). Comparative Study of Femineral® and Floradix® in Women of Child-Bearing Age and Adolescent Girls with Iron Deficiency Anaemia. Scientia Pharmaceutica, 76(4), 725-742. https://doi.org/10.3797/scipharm.0807-17

Article Metrics

Back to TopTop